X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/rd-milestone-hebabiz-biotechs-application-for-phase-iii-clinical-trial-in-china-for-clevudine-l-fmau-an-anti-hepatitis-b-virus-drug-candidate-under-development-has-been-approved-301424127.html